494 Phase II study of S-1 in combination with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer (KSCOG-BC01)
U. Toh, T. Fukushima, M. Fukunaga, N. Iwakuma, M. Takenaka, H. Otsuka, K. Shirouzu, E. OgoVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70515-2
File:
PDF, 46 KB
english, 2010